Learn / INDP
NASDAQ: INDP
Indaptus Therapeutics (INDP) stock, explained like you're 5
Indaptus Therapeutics trades on the Nasdaq under the ticker INDP. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 334 million dollars.
- Ticker
- INDP
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations
- Size
- Small cap, about 334 million dollars
Is Indaptus Therapeutics a small, medium or large cap company?
No. Indaptus Therapeutics is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 334 million dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Indaptus Therapeutics makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves INDP stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- Indaptus Therapeutics (INDP) jumps 53.8% amid heavy volume as investors focus on financing/strategic option uncertainty (Quiver Quantitative)
- Indaptus Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update (Yahoo Finance)
- Indaptus Therapeutics Extends $24 Million Private Placement Closing to Oct. 16 (TradingView)
- Insider Traders Lose US$34k As Indaptus Therapeutics Drops (Simply Wall Street)
- Why Did INDP Stock Gain 12% Today? (Stocktwits)
Follow INDP in your daily brief
Each trading day at 5 PM ET we post what happened to Indaptus Therapeutics and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow INDP
Questions about Indaptus Therapeutics stock
What does Indaptus Therapeutics do?
Indaptus Therapeutics trades on the Nasdaq under the ticker INDP. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 334 million dollars.
What is the ticker symbol for Indaptus Therapeutics?
Indaptus Therapeutics trades under the ticker INDP on the Nasdaq.
What is Indaptus Therapeutics's market cap?
Indaptus Therapeutics is a small cap stock with a market cap of about 334 million dollars.
How does Indaptus Therapeutics make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves INDP stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow INDP stock every day?
Add INDP to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.